1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of SLC1A3 mRNA CTD PMID:12832660 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of SLC1A3 mRNA CTD PMID:15834898 , PMID:17557909 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of SLC1A3 mRNA CTD PMID:20170705 , PMID:26865667 17beta-estradiol multiple interactions EXP 6480464 Estradiol inhibits the reaction [Excitatory Amino Acid Agonists results in decreased expression of SLC1A3 protein] more ... CTD PMID:19453300 , PMID:29425760 17beta-estradiol multiple interactions ISO RGD:736549 6480464 Estradiol inhibits the reaction [manganese chloride results in decreased expression of SLC1A3 mRNA], Estradiol inhibits the reaction [manganese chloride results in decreased expression of SLC1A3 protein] CTD PMID:29183790 17beta-estradiol multiple interactions ISO RGD:732126 6480464 [Estradiol co-treated with Progesterone] results in increased expression of SLC1A3 mRNA CTD PMID:20660070 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of SLC1A3 mRNA, Estradiol results in increased expression of SLC1A3 protein CTD PMID:19453300 , PMID:29425760 2,2',4,4',5,5'-hexachlorobiphenyl increases expression ISO RGD:732126 6480464 2 more ... CTD PMID:23146750 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:732126 6480464 2 more ... CTD PMID:23146750 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:736549 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC1A3 mRNA CTD PMID:19933214 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC1A3 mRNA CTD PMID:32109520 , PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:736549 6480464 Tetrachlorodibenzodioxin affects the expression of SLC1A3 mRNA CTD PMID:21570461 , PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of SLC1A3 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:732126 6480464 Tetrachlorodibenzodioxin affects the expression of SLC1A3 mRNA CTD PMID:22298810 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 2-chloroethanol decreases expression EXP 6480464 Ethylene Chlorohydrin results in decreased expression of SLC1A3 mRNA, Ethylene Chlorohydrin results in decreased expression of SLC1A3 protein CTD PMID:27596522 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:23196670 3,4-methylenedioxymethamphetamine increases expression ISO RGD:736549 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of SLC1A3 mRNA CTD PMID:20188158 3,4-methylenedioxymethamphetamine decreases expression EXP 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of SLC1A3 mRNA CTD PMID:30071829 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of SLC1A3 mRNA CTD PMID:28522335 4-hydroxyphenyl retinamide decreases expression ISO RGD:736549 6480464 Fenretinide results in decreased expression of SLC1A3 mRNA CTD PMID:28973697 4-hydroxyphenyl retinamide increases expression ISO RGD:736549 6480464 Fenretinide results in increased expression of SLC1A3 mRNA CTD PMID:28973697 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of SLC1A3 mRNA CTD PMID:30047161 7,12-dimethyltetraphene decreases expression EXP 6480464 9 more ... CTD PMID:19480007 acetamide increases expression EXP 6480464 acetamide results in increased expression of SLC1A3 mRNA CTD PMID:31881176 acrolein decreases expression EXP 6480464 Acrolein results in decreased expression of SLC1A3 protein CTD PMID:31639409 acrolein multiple interactions EXP 6480464 3-(formylhydroxyamino)-2-(3-phenyl-1-propyl)butanoic acid (2, 2-dimethyl-1-methylcarbamoyl-1-propyl)amide inhibits the reaction [Acrolein results in decreased expression of SLC1A3 protein] CTD PMID:31639409 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of SLC1A3 mRNA CTD PMID:12853321 aflatoxin B1 increases expression ISO RGD:732126 6480464 Aflatoxin B1 results in increased expression of SLC1A3 mRNA CTD PMID:22100608 agathisflavone multiple interactions EXP 6480464 agathisflavone inhibits the reaction [Excitatory Amino Acid Agonists results in decreased expression of SLC1A3 protein] CTD PMID:29425760 agathisflavone increases expression EXP 6480464 agathisflavone results in increased expression of SLC1A3 protein CTD PMID:29425760 aldehydo-D-glucose multiple interactions EXP 6480464 resveratrol inhibits the reaction [Glucose results in decreased expression of SLC1A3 mRNA], resveratrol inhibits the reaction [Glucose results in decreased expression of SLC1A3 protein] CTD PMID:26677078 aldehydo-D-glucose decreases expression EXP 6480464 Glucose results in decreased expression of SLC1A3 mRNA, Glucose results in decreased expression of SLC1A3 protein CTD PMID:26677078 all-trans-retinoic acid increases expression ISO RGD:732126 6480464 Tretinoin results in increased expression of SLC1A3 mRNA CTD PMID:21934132 amiodarone increases expression ISO RGD:732126 6480464 Amiodarone results in increased expression of SLC1A3 mRNA CTD PMID:36586010 amitrole decreases expression EXP 6480464 Amitrole results in decreased expression of SLC1A3 mRNA CTD PMID:30047161 ammonium chloride increases oxidation EXP 6480464 Ammonium Chloride results in increased oxidation of SLC1A3 mRNA CTD PMID:18506841 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of SLC1A3 mRNA CTD PMID:16483693 androgen antagonist multiple interactions EXP 6480464 [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in increased expression of SLC1A3 mRNA CTD PMID:25607892 atorvastatin calcium multiple interactions ISO RGD:736549 6480464 Atorvastatin inhibits the reaction [APP protein results in decreased expression of SLC1A3 protein] CTD PMID:20816828 belinostat multiple interactions ISO RGD:732126 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC1A3 mRNA CTD PMID:27188386 benzo[a]pyrene decreases expression ISO RGD:732126 6480464 Benzo(a)pyrene results in decreased expression of SLC1A3 mRNA CTD PMID:22316170 benzo[a]pyrene affects methylation ISO RGD:732126 6480464 Benzo(a)pyrene affects the methylation of SLC1A3 promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:732126 6480464 Benzo(a)pyrene results in increased expression of SLC1A3 protein CTD PMID:32717239 bexarotene decreases expression EXP 6480464 bexarotene results in decreased expression of SLC1A3 mRNA CTD PMID:16648578 bis(2-chloroethyl) sulfide increases expression ISO RGD:736549 6480464 Mustard Gas results in increased expression of SLC1A3 mRNA CTD PMID:15674844 bisphenol A affects expression ISO RGD:732126 6480464 bisphenol A affects the expression of SLC1A3 mRNA CTD PMID:20170705 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of SLC1A3 mRNA CTD PMID:30816183 more ... bisphenol A increases expression ISO RGD:732126 6480464 bisphenol A results in increased expression of SLC1A3 protein CTD PMID:32363662 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of SLC1A3 mRNA CTD PMID:25181051 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in increased expression of SLC1A3 mRNA, [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in increased expression of SLC1A3 mRNA CTD PMID:25607892 Brodifacoum increases expression EXP 6480464 bromfenacoum results in increased expression of SLC1A3 protein CTD PMID:28903499 bromobenzene affects expression EXP 6480464 bromobenzene affects the expression of SLC1A3 mRNA CTD PMID:32479839 Butylparaben multiple interactions EXP 6480464 [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in increased expression of SLC1A3 mRNA, [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in increased expression of SLC1A3 mRNA CTD PMID:25607892 butyric acid multiple interactions ISO RGD:736549 6480464 Butyric Acid inhibits the reaction [Manganese results in decreased expression of SLC1A3 mRNA], Butyric Acid inhibits the reaction [Manganese results in decreased expression of SLC1A3 protein] CTD PMID:28610743 calcidiol decreases expression EXP 6480464 Calcifediol deficiency results in decreased expression of SLC1A3 mRNA CTD PMID:17293106 calcitriol increases expression ISO RGD:732126 6480464 Calcitriol results in increased expression of SLC1A3 mRNA CTD PMID:27107558 captan decreases expression ISO RGD:736549 6480464 Captan results in decreased expression of SLC1A3 mRNA CTD PMID:31558096 carbon nanotube decreases expression ISO RGD:736549 6480464 Nanotubes, Carbon analog results in decreased expression of SLC1A3 mRNA CTD PMID:25554681 CGP 52608 multiple interactions ISO RGD:732126 6480464 CGP 52608 promotes the reaction [RORA protein binds to SLC1A3 gene] CTD PMID:28238834 chloroprene decreases expression ISO RGD:736549 6480464 Chloroprene results in decreased expression of SLC1A3 mRNA CTD PMID:23125180 chlorpyrifos increases expression EXP 6480464 Chlorpyrifos results in increased expression of SLC1A3 mRNA CTD PMID:20600679 chlorpyrifos multiple interactions ISO RGD:736549 6480464 [Chlorpyrifos co-treated with NGF protein] results in increased expression of SLC1A3 mRNA CTD PMID:20600679 cholesterol increases expression ISO RGD:732126 6480464 Cholesterol results in increased expression of SLC1A3 mRNA CTD PMID:26296894 cisplatin affects response to substance ISO RGD:732126 6480464 SLC1A3 mRNA affects the susceptibility to Cisplatin CTD PMID:18610736 cobalt dichloride decreases expression ISO RGD:732126 6480464 cobaltous chloride results in decreased expression of SLC1A3 mRNA CTD PMID:22941251 copper atom increases expression EXP 6480464 Copper deficiency results in increased expression of SLC1A3 mRNA CTD PMID:26033743 copper atom multiple interactions ISO RGD:732126 6480464 [NSC 689534 binds to Copper] which results in decreased expression of SLC1A3 mRNA CTD PMID:20971185 copper(0) increases expression EXP 6480464 Copper deficiency results in increased expression of SLC1A3 mRNA CTD PMID:26033743 copper(0) multiple interactions ISO RGD:732126 6480464 [NSC 689534 binds to Copper] which results in decreased expression of SLC1A3 mRNA CTD PMID:20971185 coumarin decreases phosphorylation ISO RGD:732126 6480464 coumarin results in decreased phosphorylation of SLC1A3 protein CTD PMID:35688186 crocidolite asbestos increases expression ISO RGD:736549 6480464 Asbestos, Crocidolite results in increased expression of SLC1A3 mRNA CTD PMID:19446018 curcumin multiple interactions EXP 6480464 Curcumin inhibits the reaction [Streptozocin results in decreased expression of SLC1A3 mRNA] CTD PMID:23267840 D-glucose multiple interactions EXP 6480464 resveratrol inhibits the reaction [Glucose results in decreased expression of SLC1A3 mRNA], resveratrol inhibits the reaction [Glucose results in decreased expression of SLC1A3 protein] CTD PMID:26677078 D-glucose decreases expression EXP 6480464 Glucose results in decreased expression of SLC1A3 mRNA, Glucose results in decreased expression of SLC1A3 protein CTD PMID:26677078 dexamethasone decreases expression ISO RGD:736549 6480464 Dexamethasone results in decreased expression of SLC1A3 mRNA CTD PMID:22733784 dexamethasone decreases expression ISO RGD:732126 6480464 Dexamethasone results in decreased expression of SLC1A3 mRNA CTD PMID:25047013 diazepam increases oxidation EXP 6480464 Diazepam results in increased oxidation of SLC1A3 mRNA CTD PMID:18506841 diazinon decreases expression EXP 6480464 Diazinon results in decreased expression of SLC1A3 mRNA CTD PMID:17452286 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of SLC1A3 mRNA CTD PMID:21266533 dioxygen multiple interactions EXP 6480464 [SCH 442416 co-treated with Oxygen deficiency] results in increased expression of SLC1A3 mRNA CTD PMID:22969972 dorsomorphin multiple interactions ISO RGD:732126 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:732126 6480464 Doxorubicin results in decreased expression of SLC1A3 mRNA CTD PMID:29803840 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of SLC1A3 mRNA CTD PMID:29391264 enzacamene multiple interactions EXP 6480464 [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in increased expression of SLC1A3 mRNA, [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in increased expression of SLC1A3 mRNA CTD PMID:25607892 ethanol affects expression EXP 6480464 Ethanol affects the expression of SLC1A3 mRNA CTD PMID:11772933 ethanol affects splicing ISO RGD:736549 6480464 Ethanol affects the splicing of SLC1A3 mRNA CTD PMID:30319688 ethanol increases expression ISO RGD:736549 6480464 Ethanol results in increased expression of SLC1A3 mRNA CTD PMID:30319688 ethanol increases expression EXP 6480464 Ethanol results in increased expression of SLC1A3 mRNA CTD PMID:20655511 excitatory amino acid agonist multiple interactions EXP 6480464 agathisflavone inhibits the reaction [Excitatory Amino Acid Agonists results in decreased expression of SLC1A3 protein], Estradiol inhibits the reaction [Excitatory Amino Acid Agonists results in decreased expression of SLC1A3 protein] CTD PMID:29425760 excitatory amino acid agonist decreases expression EXP 6480464 Excitatory Amino Acid Agonists results in decreased expression of SLC1A3 protein CTD PMID:29425760 folpet decreases expression ISO RGD:736549 6480464 folpet results in decreased expression of SLC1A3 mRNA CTD PMID:31558096 furan increases expression EXP 6480464 furan results in increased expression of SLC1A3 mRNA CTD PMID:27387713 genistein decreases expression ISO RGD:732126 6480464 Genistein results in decreased expression of SLC1A3 mRNA CTD PMID:26865667 genistein decreases expression ISO RGD:736549 6480464 Genistein results in decreased expression of SLC1A3 mRNA CTD PMID:32186404 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of SLC1A3 mRNA CTD PMID:33387578 glucose multiple interactions EXP 6480464 resveratrol inhibits the reaction [Glucose results in decreased expression of SLC1A3 mRNA], resveratrol inhibits the reaction [Glucose results in decreased expression of SLC1A3 protein] CTD PMID:26677078 glucose decreases expression EXP 6480464 Glucose results in decreased expression of SLC1A3 mRNA, Glucose results in decreased expression of SLC1A3 protein CTD PMID:26677078 haloperidol decreases expression EXP 6480464 Haloperidol results in decreased expression of SLC1A3 mRNA CTD PMID:15860345 hexadecanoic acid decreases phosphorylation ISO RGD:732126 6480464 Palmitic Acid results in decreased phosphorylation of SLC1A3 protein CTD PMID:28073184 hydrogen peroxide affects expression ISO RGD:732126 6480464 Hydrogen Peroxide affects the expression of SLC1A3 mRNA CTD PMID:20044591 ivermectin decreases expression ISO RGD:732126 6480464 Ivermectin results in decreased expression of SLC1A3 protein CTD PMID:32959892 kanamycin A affects response to substance ISO RGD:736549 6480464 SLC1A3 affects the susceptibility to Kanamycin CTD PMID:15862894 lead diacetate affects expression EXP 6480464 lead acetate affects the expression of SLC1A3 mRNA CTD PMID:15985313 lead diacetate increases expression EXP 6480464 lead acetate results in increased expression of SLC1A3 mRNA CTD PMID:11578147 lead(0) increases expression EXP 6480464 Lead results in increased expression of SLC1A3 mRNA, Lead results in increased expression of SLC1A3 protein CTD PMID:15955607 manganese atom multiple interactions EXP 6480464 Estradiol inhibits the reaction [Manganese results in decreased expression of SLC1A3 mRNA] more ... CTD PMID:19453300 manganese atom decreases expression ISO RGD:736549 6480464 Manganese results in decreased expression of SLC1A3 mRNA, Manganese results in decreased expression of SLC1A3 protein CTD PMID:28610743 manganese atom multiple interactions ISO RGD:736549 6480464 Butyric Acid inhibits the reaction [Manganese results in decreased expression of SLC1A3 mRNA] more ... CTD PMID:28610743 manganese atom decreases expression EXP 6480464 Manganese results in decreased expression of SLC1A3 mRNA, Manganese results in decreased expression of SLC1A3 protein CTD PMID:19453300 manganese(0) multiple interactions EXP 6480464 Estradiol inhibits the reaction [Manganese results in decreased expression of SLC1A3 mRNA] more ... CTD PMID:19453300 manganese(0) decreases expression ISO RGD:736549 6480464 Manganese results in decreased expression of SLC1A3 mRNA, Manganese results in decreased expression of SLC1A3 protein CTD PMID:28610743 manganese(0) multiple interactions ISO RGD:736549 6480464 Butyric Acid inhibits the reaction [Manganese results in decreased expression of SLC1A3 mRNA] more ... CTD PMID:28610743 manganese(0) decreases expression EXP 6480464 Manganese results in decreased expression of SLC1A3 mRNA, Manganese results in decreased expression of SLC1A3 protein CTD PMID:19453300 manganese(II) chloride multiple interactions EXP 6480464 Raloxifene Hydrochloride inhibits the reaction [manganese chloride results in decreased expression of SLC1A3 protein] more ... CTD PMID:19615351 , PMID:24782323 manganese(II) chloride multiple interactions ISO RGD:732126 6480464 Valproic Acid inhibits the reaction [manganese chloride results in decreased expression of SLC1A3 mRNA], Valproic Acid inhibits the reaction [manganese chloride results in decreased expression of SLC1A3 protein] CTD PMID:29778792 manganese(II) chloride decreases expression ISO RGD:732126 6480464 manganese chloride results in decreased expression of SLC1A3 mRNA, manganese chloride results in decreased expression of SLC1A3 protein CTD PMID:29778792 manganese(II) chloride decreases expression ISO RGD:736549 6480464 manganese chloride results in decreased expression of SLC1A3 mRNA, manganese chloride results in decreased expression of SLC1A3 protein CTD PMID:29183790 , PMID:29778792 manganese(II) chloride multiple interactions ISO RGD:736549 6480464 Estradiol inhibits the reaction [manganese chloride results in decreased expression of SLC1A3 mRNA] more ... CTD PMID:29183790 , PMID:29778792 manganese(II) chloride decreases expression EXP 6480464 manganese chloride results in decreased expression of SLC1A3 mRNA, manganese chloride results in decreased expression of SLC1A3 protein CTD PMID:12387356 more ... manganese(II) sulfate decreases expression EXP 6480464 manganese sulfate results in decreased expression of SLC1A3 mRNA CTD PMID:12387356 medroxyprogesterone acetate increases expression ISO RGD:732126 6480464 Medroxyprogesterone Acetate results in increased expression of SLC1A3 mRNA CTD PMID:20843944 methamphetamine increases expression EXP 6480464 Methamphetamine results in increased expression of SLC1A3 mRNA CTD PMID:18419818 methimazole decreases expression EXP 6480464 Methimazole results in decreased expression of SLC1A3 mRNA CTD PMID:30047161 methylmercury chloride multiple interactions EXP 6480464 methylmercuric chloride results in decreased expression of and results in decreased activity of SLC1A3 protein more ... CTD PMID:22966415 methylmercury chloride decreases expression EXP 6480464 methylmercuric chloride results in decreased expression of SLC1A3 mRNA CTD PMID:22966415 mono(2-ethylhexyl) phthalate decreases expression ISO RGD:732126 6480464 mono-(2-ethylhexyl)phthalate results in decreased expression of SLC1A3 mRNA CTD PMID:36695872 ochratoxin A affects expression EXP 6480464 ochratoxin A affects the expression of SLC1A3 protein CTD PMID:20558201 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of SLC1A3 mRNA CTD PMID:25729387 oxaliplatin increases expression EXP 6480464 oxaliplatin results in increased expression of SLC1A3 mRNA CTD PMID:25729387 oxidopamine increases expression EXP 6480464 Oxidopamine results in increased expression of SLC1A3 mRNA CTD PMID:15518916 ozone decreases expression ISO RGD:736549 6480464 Ozone results in decreased expression of SLC1A3 mRNA CTD PMID:17095637 ozone multiple interactions ISO RGD:736549 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of SLC1A3 mRNA CTD PMID:34911549 paclitaxel decreases expression EXP 6480464 Paclitaxel results in decreased expression of SLC1A3 protein CTD PMID:16361064 panobinostat multiple interactions ISO RGD:732126 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC1A3 mRNA CTD PMID:27188386 panobinostat increases expression ISO RGD:732126 6480464 panobinostat results in increased expression of SLC1A3 mRNA CTD PMID:26272509 paracetamol multiple interactions EXP 6480464 [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in increased expression of SLC1A3 mRNA CTD PMID:25607892 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of SLC1A3 mRNA CTD PMID:33387578 paracetamol decreases expression ISO RGD:732126 6480464 Acetaminophen results in decreased expression of SLC1A3 mRNA CTD PMID:29067470 paraoxon increases expression EXP 6480464 Paraoxon results in increased expression of SLC1A3 mRNA, Paraoxon results in increased expression of SLC1A3 protein CTD PMID:27769869 paraoxon affects expression EXP 6480464 Paraoxon affects the expression of SLC1A3 mRNA, Paraoxon affects the expression of SLC1A3 protein CTD PMID:28603072 PCB138 increases expression EXP 6480464 2 more ... CTD PMID:21673325 perfluorooctane-1-sulfonic acid affects expression ISO RGD:736549 6480464 perfluorooctane sulfonic acid affects the expression of SLC1A3 mRNA CTD PMID:19429403 perfluorooctane-1-sulfonic acid decreases expression EXP 6480464 perfluorooctane sulfonic acid results in decreased expression of SLC1A3 mRNA CTD PMID:18692542 , PMID:27825932 perfluorooctanoic acid affects expression ISO RGD:736549 6480464 perfluorooctanoic acid affects the expression of SLC1A3 mRNA CTD PMID:19429403 phenylephrine increases expression EXP 6480464 Phenylephrine results in increased expression of SLC1A3 mRNA CTD PMID:18158353 picoxystrobin increases expression ISO RGD:732126 6480464 picoxystrobin results in increased expression of SLC1A3 mRNA CTD PMID:33512557 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of SLC1A3 mRNA CTD PMID:12832660 pregnenolone 16alpha-carbonitrile decreases expression EXP 6480464 Pregnenolone Carbonitrile results in decreased expression of SLC1A3 mRNA CTD PMID:19162173 , PMID:30047161 progesterone multiple interactions ISO RGD:732126 6480464 [Estradiol co-treated with Progesterone] results in increased expression of SLC1A3 mRNA CTD PMID:20660070 pyrrolidine dithiocarbamate multiple interactions EXP 6480464 pyrrolidine dithiocarbamic acid inhibits the reaction [Raloxifene Hydrochloride results in increased expression of SLC1A3 mRNA], pyrrolidine dithiocarbamic acid inhibits the reaction [Raloxifene Hydrochloride results in increased expression of SLC1A3 protein] CTD PMID:24782323 raloxifene increases expression EXP 6480464 Raloxifene Hydrochloride results in increased expression of SLC1A3 mRNA, Raloxifene Hydrochloride results in increased expression of SLC1A3 protein CTD PMID:24782323 raloxifene multiple interactions EXP 6480464 [4-(6-bromo-1 more ... CTD PMID:24782323 resveratrol multiple interactions EXP 6480464 Resveratrol inhibits the reaction [Glucose results in decreased expression of SLC1A3 mRNA] more ... CTD PMID:26677078 Riluzole multiple interactions EXP 6480464 Riluzole inhibits the reaction [manganese chloride results in decreased expression of SLC1A3 mRNA] more ... CTD PMID:19615351 , PMID:22966415 Riluzole increases expression EXP 6480464 Riluzole results in increased expression of SLC1A3 mRNA, Riluzole results in increased expression of SLC1A3 protein CTD PMID:22966415 SB 431542 multiple interactions ISO RGD:732126 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 sodium arsenite multiple interactions EXP 6480464 sodium arsenite results in decreased expression of and results in decreased activity of SLC1A3 protein CTD PMID:22020379 sodium arsenite increases expression ISO RGD:736549 6480464 sodium arsenite results in increased expression of SLC1A3 mRNA, sodium arsenite results in increased expression of SLC1A3 protein CTD PMID:31170414 , PMID:32194376 sodium arsenite increases expression ISO RGD:732126 6480464 sodium arsenite results in increased expression of SLC1A3 mRNA CTD PMID:22714537 , PMID:29301061 streptozocin multiple interactions EXP 6480464 Curcumin inhibits the reaction [Streptozocin results in decreased expression of SLC1A3 mRNA] more ... CTD PMID:23267840 , PMID:26677078 streptozocin decreases expression EXP 6480464 Streptozocin results in decreased expression of SLC1A3 mRNA, Streptozocin results in decreased expression of SLC1A3 protein CTD PMID:23267840 , PMID:26677078 sulfadimethoxine decreases expression EXP 6480464 Sulfadimethoxine results in decreased expression of SLC1A3 mRNA CTD PMID:30047161 sulforaphane increases expression ISO RGD:732126 6480464 sulforaphane results in increased expression of SLC1A3 mRNA CTD PMID:31838189 sunitinib decreases expression ISO RGD:732126 6480464 Sunitinib results in decreased expression of SLC1A3 mRNA CTD PMID:31533062 tamoxifen multiple interactions EXP 6480464 Tamoxifen inhibits the reaction [Manganese results in decreased expression of SLC1A3 mRNA], Tamoxifen inhibits the reaction [Manganese results in decreased expression of SLC1A3 protein] CTD PMID:19453300 tamoxifen multiple interactions ISO RGD:736549 6480464 Tamoxifen inhibits the reaction [manganese chloride results in decreased expression of SLC1A3 mRNA], Tamoxifen inhibits the reaction [manganese chloride results in decreased expression of SLC1A3 protein] CTD PMID:29183790 tamoxifen increases expression EXP 6480464 Tamoxifen results in increased expression of SLC1A3 mRNA, Tamoxifen results in increased expression of SLC1A3 protein CTD PMID:19453300 testosterone increases expression ISO RGD:732126 6480464 Testosterone results in increased expression of SLC1A3 mRNA CTD PMID:33359661 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of SLC1A3 protein CTD PMID:17544377 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of SLC1A3 mRNA CTD PMID:34492290 titanium dioxide increases expression ISO RGD:736549 6480464 titanium dioxide results in increased expression of SLC1A3 mRNA CTD PMID:23557971 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of SLC1A3 mRNA CTD PMID:25729387 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of SLC1A3 mRNA CTD PMID:33387578 trichostatin A increases expression ISO RGD:732126 6480464 trichostatin A results in increased expression of SLC1A3 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:732126 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC1A3 mRNA CTD PMID:27188386 triclosan decreases expression ISO RGD:732126 6480464 Triclosan results in decreased expression of SLC1A3 mRNA CTD PMID:30510588 trimellitic anhydride decreases expression ISO RGD:736549 6480464 trimellitic anhydride results in decreased expression of SLC1A3 mRNA CTD PMID:19042947 tunicamycin increases expression ISO RGD:736549 6480464 Tunicamycin results in increased expression of SLC1A3 mRNA CTD PMID:17127020 valproic acid multiple interactions ISO RGD:736549 6480464 Valproic Acid inhibits the reaction [manganese chloride results in decreased expression of SLC1A3 mRNA] more ... CTD PMID:28610743 , PMID:29778792 valproic acid multiple interactions ISO RGD:732126 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 , PMID:29778792 valproic acid increases expression ISO RGD:732126 6480464 Valproic Acid results in increased expression of SLC1A3 mRNA, Valproic Acid results in increased expression of SLC1A3 protein CTD PMID:23179753 more ... valproic acid affects expression ISO RGD:732126 6480464 Valproic Acid affects the expression of SLC1A3 mRNA CTD PMID:25979313 valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of SLC1A3 mRNA CTD PMID:23665938 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of SLC1A3 mRNA CTD PMID:22570695 vorinostat increases expression ISO RGD:732126 6480464 vorinostat results in increased expression of SLC1A3 mRNA CTD PMID:26272509 vorinostat multiple interactions ISO RGD:732126 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC1A3 mRNA CTD PMID:27188386 XL147 multiple interactions ISO RGD:736549 6480464 XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of SLC1A3 mRNA] CTD PMID:29891994 zoledronic acid increases expression ISO RGD:732126 6480464 zoledronic acid results in increased expression of SLC1A3 mRNA CTD PMID:24714768